Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Bartenstein

Showing results (461-470 of 546) with videos related to

Pageof 55
Sort By:
Neuroimage. Clinical|August 4, 2023
Assessment of synaptic loss in mouse models of β-amyloid and tau pathology using [<sup>18</sup>F]UCB-H PET imagingLetizia Vogler, Anna Ballweg, Bernd Bohr, et al.
Frontiers in Aging Neuroscience|February 2, 2018
[<sup>18</sup>F]-THK5351 PET Correlates with Topology and Symptom Severity in Progressive Supranuclear PalsyMatthias Brendel, Sonja Schönecker, Günter Höglinger, et al.
Thyroid : Official Journal of the American Thyroid Association|September 18, 2013
High-risk patients with differentiated thyroid cancer T4 primary tumors achieve remnant ablation equally well using rhTSH or thyroid hormone withdrawalPeter Bartenstein, Elisa Caballero Calabuig, Carlo Ludovico Maini, et al.
Journal of Neuroinflammation|December 15, 2020
Glial activation is moderated by sex in response to amyloidosis but not to tau pathology in mouse models of neurodegenerative diseasesGloria Biechele, Nicolai Franzmeier, Tanja Blume, et al.
Frontiers in Aging Neuroscience|May 31, 2021
Dual-Phase β-Amyloid PET Captures Neuronal Injury and Amyloidosis in Corticobasal SyndromeJulia Schmitt, Carla Palleis, Julia Sauerbeck, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 8, 2024
Assessment of [<sup>18</sup>F]PI-2620 Tau-PET Quantification via Non-Invasive Automatized Image Derived Input FunctionMaria Meindl, Artem Zatcepin, Johannes Gnörich, et al.
Frontiers in Neurology|July 19, 2021
Superiority of Formalin-Fixed Paraffin-Embedded Brain Tissue for <i>in vitro</i> Assessment of Progressive Supranuclear Palsy Tau Pathology With [ <sup></sup> F]PI-2620Marie Willroider, Sigrun Roeber, Anja K E Horn, et al.
Biomedicines|April 23, 2022
Longitudinal [<sup>18</sup>F]GE-180 PET Imaging Facilitates In Vivo Monitoring of TSPO Expression in the GL261 Glioblastoma Mouse ModelAdrien Holzgreve, Dennis Pötter, Matthias Brendel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2021
Glitter in the Darkness? Nonfibrillar β-Amyloid Plaque Components Significantly Impact the β-Amyloid PET Signal in Mouse Models of Alzheimer DiseaseGloria Biechele, Laura Sebastian Monasor, Karin Wind, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 15, 2019
Longitudinal PET Monitoring of Amyloidosis and Microglial Activation in a Second-Generation Amyloid-β Mouse ModelChristian Sacher, Tanja Blume, Leonie Beyer, et al.
Pageof 55

Showing results (461-470 of 546) with videos related to

Sort By:
Pageof 55
Neuroimage. Clinical|August 4, 2023
Assessment of synaptic loss in mouse models of β-amyloid and tau pathology using [<sup>18</sup>F]UCB-H PET imagingLetizia Vogler, Anna Ballweg, Bernd Bohr, et al.
Frontiers in Aging Neuroscience|February 2, 2018
[<sup>18</sup>F]-THK5351 PET Correlates with Topology and Symptom Severity in Progressive Supranuclear PalsyMatthias Brendel, Sonja Schönecker, Günter Höglinger, et al.
Thyroid : Official Journal of the American Thyroid Association|September 18, 2013
High-risk patients with differentiated thyroid cancer T4 primary tumors achieve remnant ablation equally well using rhTSH or thyroid hormone withdrawalPeter Bartenstein, Elisa Caballero Calabuig, Carlo Ludovico Maini, et al.
Journal of Neuroinflammation|December 15, 2020
Glial activation is moderated by sex in response to amyloidosis but not to tau pathology in mouse models of neurodegenerative diseasesGloria Biechele, Nicolai Franzmeier, Tanja Blume, et al.
Frontiers in Aging Neuroscience|May 31, 2021
Dual-Phase β-Amyloid PET Captures Neuronal Injury and Amyloidosis in Corticobasal SyndromeJulia Schmitt, Carla Palleis, Julia Sauerbeck, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 8, 2024
Assessment of [<sup>18</sup>F]PI-2620 Tau-PET Quantification via Non-Invasive Automatized Image Derived Input FunctionMaria Meindl, Artem Zatcepin, Johannes Gnörich, et al.
Frontiers in Neurology|July 19, 2021
Superiority of Formalin-Fixed Paraffin-Embedded Brain Tissue for <i>in vitro</i> Assessment of Progressive Supranuclear Palsy Tau Pathology With [ <sup></sup> F]PI-2620Marie Willroider, Sigrun Roeber, Anja K E Horn, et al.
Biomedicines|April 23, 2022
Longitudinal [<sup>18</sup>F]GE-180 PET Imaging Facilitates In Vivo Monitoring of TSPO Expression in the GL261 Glioblastoma Mouse ModelAdrien Holzgreve, Dennis Pötter, Matthias Brendel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2021
Glitter in the Darkness? Nonfibrillar β-Amyloid Plaque Components Significantly Impact the β-Amyloid PET Signal in Mouse Models of Alzheimer DiseaseGloria Biechele, Laura Sebastian Monasor, Karin Wind, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 15, 2019
Longitudinal PET Monitoring of Amyloidosis and Microglial Activation in a Second-Generation Amyloid-β Mouse ModelChristian Sacher, Tanja Blume, Leonie Beyer, et al.
Pageof 55